3i invests in WilsonHCG to build the leader in global talent solutions
3i Group plc (“3i Group”) announces that it has agreed to invest $120m of equity in Wilson Human Capital Group (“WilsonHCG”), an award-winning global leader in talent solutions.
Headquartered in Tampa, Florida, WilsonHCG is a global business with offices throughout North America, Europe and Asia. The company provides a full suite of configurable talent solutions including recruitment process outsourcing (“RPO”), executive search, contingent talent solutions and talent consulting. The Company has operated as a strategic partner to some of the world’s most admired brands in helping them plan and execute on talent acquisition on a global basis.
WilsonHCG is widely known for its high-performance culture including its core values of collaboration, ownership, integrity, passion and communication. As a result, the Company is recognised as a leader by various industry trade associations such as HRO Today, Everest Group, NelsonHall and SIA and has also won a Gold Stevie Award and the Best Onsite RPO award in recent years.
The recruitment process outsourcing sector, which is one of WilsonHCG’s core areas of focus, has grown at a double-digit growth rate due to continued outsourcing adoption by new clients, further penetration with existing clients and increased hiring driven by greater employee mobility. Post the Covid-19 pandemic, the market is expected to return to historical levels of growth as companies increasingly value the superior outcomes, flexibility and efficiency that RPO providers such as WilsonHCG provide their clients.
Andrew Olinick, Partner, 3i, commented: “We are delighted to be backing John and his management team and investing in WilsonHCG. We have tracked the RPO space and WilsonHCG for several years. WilsonHCG’s high-performance culture and deep commitment to driving superior outcomes for its clients give us conviction that the Company will continue to grow rapidly in its markets. The business is highly regarded and is continuing its international expansion journey, following the recent acquisition of Profile in Asia, where we see the opportunity for WilsonHCG to serve its clients across all talent acquisition solutions.”
John Wilson, Founder and CEO, WilsonHCG, added: “We have known the 3i team for a number of years and they have demonstrated a clear commitment to investing in our space. There is a strong cultural fit between our organisations and a shared ambition to continue building WilsonHCG into the global talent solutions leader. Further, 3i’s international network will enable us to continue expanding our already global footprint so we can serve our customers in even more international locations.”
-ends-
For further information, contact:
3i Group plc
Silvia Santoro |
Tel: +44 20 7975 3258 |
Kathryn van der Kroft |
Tel: +44 7721 886 304 |
About 3i Group
3i is an investment company with two complementary businesses, Private Equity and Infrastructure, specialising in core investment markets in Northern Europe and North America.
3i’s Private Equity team provides investment solutions for growing companies, backing entrepreneurs and management teams of mid-market companies with an EV typically between €100m - €500m. We back international growth plans, providing access to our network and expertise to accelerate the growth of companies across the consumer, industrial, healthcare and business and technology services industries.
For further information, please visit: www.3i.com
About WilsonHCG
WilsonHCG is an award-winning, global leader in total talent solutions. Operating as a strategic partner, it helps some of the world’s most admired brands build comprehensive talent functions. With a global presence spanning more than 65 countries and six continents, WilsonHCG provides a full suite of configurable talent services including recruitment process outsourcing (“RPO”), executive search, contingent talent solutions and technology advisory.
TALENT. ™ It’s more than a solution; it’s who we are.
Regulatory information
This transaction involved a recommendation of 3i Corporation, a US wholly owned subsidiary of 3i Group.